Optimal medical therapy in patients with reduced left ejection fraction undergoing coronary artery bypass graft surgery
The prescription rate of OMT increased until the 2 months follow-up with no further increases in dose at 1 year and 2 years follow-up. Patients undergoing CABG with a preoperative reduced left ventricular ejection fraction that were prescribed OMT at discharge had better outcomes in terms of a reduced risk of hospitalization for heart failure and all-cause mortality.
Authors
- Safian Sharif (ORCID: https://orcid.org/0000-0002-3418-2290)
- Krister Lindmark (ORCID: https://orcid.org/0000-0002-5756-7791)
- Mattias Karlsson
- Anna Jonsson (ORCID: https://orcid.org/0000-0001-9319-0242)
- Erik Birring
Institutions
- Karolinska Institutet (SE)
- Umeå University (SE)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1186/s12872-025-05384-2
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00